As clinicians, recognizing that people can get double benefits from something is always helpful and as more obesity medications enter the market, this can help personalize treatments, she said
The aforementioned studies were completed through IV administration of proteins which is not feasible in the treatment of a chronic disease
100mcg Copper (as copper glycinate)
The exact mechanisms through which activation of THR improves MASH are still unclear but are known to control fat synthesis, regulate fatty acid oxidation, regulate cholesterol metabolism, improve mitochondrial function, and reduce inflammation and fibrosis
Baseline bloodwork before starting: Total and free testosterone LH, FSH Estradiol Thyroid panel (TSH, T3, T4) Lipids (cholesterol panel) Liver enzymes Kidney function IGF-1 (if using GH peptides) Glucose and HbA1c Follow-up testing: 6-8 weeks after starting Every 3-4 months during use Track changes and adjust protocols accordingly Why it matters: Verify peptides are working (testosterone increasing, IGF-1 rising, etc.) Catch any issues early (rare but possible) Optimize dosing based on response Have objective data, not just subjective feelings Storage and handling Peptides are sensitive to heat, light, and air